Skip to main content

Video+

Podcasts

EASD 2020: Editorial Board conference highlights

EASD 2020: Editorial Board conference highlights

Listen to Sanjay Kalra, John Wilding and Lori Berard reflecting on their research highlights of this year’s virtual 56th EASD Annual Meeting (39:05). 

William Polonsky on disengagement with diabetes

William Polonsky on disengagement with diabetes

William Polonsky discusses the problem of people being disengaged with their diabetes, why this issue is so critical yet remains so understudied, and what healthcare professionals can do in the clinic to encourage engagement. 
Part of the 'Why psychosocial care matters' collection, visit the hub to learn more.

William Polonsky on diabetes distress

William Polonsky on diabetes distress

William Polonsky talks about how diabetes distress affects the wellbeing and glucose management of people with diabetes, and what healthcare professionals can do to help (15:48).

Part of the 'Why psychosocial care matters' collection, visit the hub to learn more.

Frank Snoek on the role of the Psychosocial Aspects of Diabetes study group

Frank Snoek on the role of the Psychosocial Aspects of Diabetes study group

To begin our podcast series marking the 25th anniversary of the PSAD, we talk to founder Frank Snoek about its history and achievements, and the changing profile of psychosocial research in diabetes care (19:40). 

Part of the 'Why psychosocial care matters' collection, visit the hub to learn more.

The DiRECT approach to weight loss: Efficacious and pragmatic

The DiRECT approach to weight loss: Efficacious and pragmatic

DiRECT trial dietician Alison Barnes discusses the challenges and triumphs of using a very-low-calorie, total-meal-replacement diet to help people with type 2 diabetes achieve weight loss and maintenance (25:34).

Expert commentary: Closed-loop insulin delivery research update

Expert commentary: Closed-loop insulin delivery research update

Engineer turned endocrinologist Rayhan Lal reflects on the shape of artificial pancreas research and what changes are needed to best benefit people with diabetes (18:54).

Is oral semaglutide a game changer or nice-to-have for type 2 diabetes?

Is oral semaglutide a game changer or nice-to-have for type 2 diabetes?

US primary care physician Neil Skolnik discusses the role of oral semaglutide in the care of people with type 2 diabetes and outlines key considerations for its use (12:26).